150 related articles for article (PubMed ID: 8781144)
1. Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma.
Yeh SH; Liu RS; Wu LC; Yang DJ; Yen SH; Chang CW; Yu TW; Chou KL; Chen KY
Eur J Nucl Med; 1996 Oct; 23(10):1378-83. PubMed ID: 8781144
[TBL] [Abstract][Full Text] [Related]
2. Detection of anaerobic odontogenic infections by fluorine-18 fluoromisonidazole.
Liu RS; Chu LS; Yen SH; Chang CP; Chou KL; Wu LC; Chang CW; Lui MT; Chen KY; Yeh SH
Eur J Nucl Med; 1996 Oct; 23(10):1384-7. PubMed ID: 8781145
[TBL] [Abstract][Full Text] [Related]
3. [18F]fluoromisonidazole and a new PET system with semiconductor detectors and a depth of interaction system for intensity modulated radiation therapy for nasopharyngeal cancer.
Yasuda K; Onimaru R; Okamoto S; Shiga T; Katoh N; Tsuchiya K; Suzuki R; Takeuchi W; Kuge Y; Tamaki N; Shirato H
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):142-7. PubMed ID: 22583608
[TBL] [Abstract][Full Text] [Related]
4. Introducing fluorine-18 fluoromisonidazole positron emission tomography for the localisation and quantification of pig liver hypoxia.
Piert M; Machulla H; Becker G; Stahlschmidt A; Patt M; Aldinger P; Dissmann PD; Fischer H; Bares R; Becker HD; Lauchart W
Eur J Nucl Med; 1999 Feb; 26(2):95-109. PubMed ID: 9933343
[TBL] [Abstract][Full Text] [Related]
5. Local relapse of nasopharyngeal cancer and Voxel-based analysis of FMISO uptake using PET with semiconductor detectors.
Nishikawa Y; Yasuda K; Okamoto S; Ito YM; Onimaru R; Shiga T; Tsuchiya K; Watanabe S; Takeuchi W; Kuge Y; Peng H; Tamaki N; Shirato H
Radiat Oncol; 2017 Sep; 12(1):148. PubMed ID: 28877734
[TBL] [Abstract][Full Text] [Related]
6. 11C-acetate clearance in nasopharyngeal carcinoma.
Yeh SH; Liu RS; Wu LC; Yen SH; Chang CW; Chen KY
Nucl Med Commun; 1999 Feb; 20(2):131-4. PubMed ID: 10088161
[TBL] [Abstract][Full Text] [Related]
7. Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes?
Yen TC; Chang YC; Chan SC; Chang JT; Hsu CH; Lin KJ; Lin WJ; Fu YK; Ng SH
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):541-8. PubMed ID: 15625603
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucose.
Bentzen L; Keiding S; Horsman MR; Falborg L; Hansen SB; Overgaard J
Acta Oncol; 2000; 39(5):629-37. PubMed ID: 11093372
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.
Eschmann SM; Paulsen F; Reimold M; Dittmann H; Welz S; Reischl G; Machulla HJ; Bares R
J Nucl Med; 2005 Feb; 46(2):253-60. PubMed ID: 15695784
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Optimal Post-Injection Timing of Hypoxic Imaging with
Kawamura M; Yoshimura M; Shimizu Y; Sano K; Ishimori T; Nakamoto Y; Mizowaki T; Hiraoka M
Mol Imaging Biol; 2021 Aug; 23(4):597-603. PubMed ID: 33475945
[TBL] [Abstract][Full Text] [Related]
11. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.
Okamoto S; Shiga T; Yasuda K; Ito YM; Magota K; Kasai K; Kuge Y; Shirato H; Tamaki N
J Nucl Med; 2013 Feb; 54(2):201-7. PubMed ID: 23321456
[TBL] [Abstract][Full Text] [Related]
12.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
13. NanoPET imaging of [(18)F]fluoromisonidazole uptake in experimental mouse tumours.
Wyss MT; Honer M; Schubiger PA; Ametamey SM
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):311-8. PubMed ID: 16258762
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the distribution of fluorine-18 fluoromisonidazole, deoxyglucose and methionine in tumour tissue.
Kubota K; Tada M; Yamada S; Hori K; Saito S; Iwata R; Sato K; Fukuda H; Ido T
Eur J Nucl Med; 1999 Jul; 26(7):750-7. PubMed ID: 10398823
[TBL] [Abstract][Full Text] [Related]
15. Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice.
Schütze C; Bergmann R; Brüchner K; Mosch B; Yaromina A; Zips D; Hessel F; Krause M; Thames H; Kotzerke J; Steinbach J; Baumann M; Beuthien-Baumann B
Radiother Oncol; 2014 Apr; 111(1):81-7. PubMed ID: 24636842
[TBL] [Abstract][Full Text] [Related]
16. Correlation between tumor oxygenation and 18F-fluoromisonidazole PET data simulated based on microvessel images.
Mönnich D; Troost EG; Kaanders JH; Oyen WJ; Alber M; Zips D; Thorwarth D
Acta Oncol; 2013 Oct; 52(7):1308-13. PubMed ID: 23984808
[TBL] [Abstract][Full Text] [Related]
17. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole.
Koh WJ; Rasey JS; Evans ML; Grierson JR; Lewellen TK; Graham MM; Krohn KA; Griffin TW
Int J Radiat Oncol Biol Phys; 1992; 22(1):199-212. PubMed ID: 1727119
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole.
Valk PE; Mathis CA; Prados MD; Gilbert JC; Budinger TF
J Nucl Med; 1992 Dec; 33(12):2133-7. PubMed ID: 1334136
[TBL] [Abstract][Full Text] [Related]
19. ¹⁸F-HX4 hypoxia imaging with PET/CT in head and neck cancer: a comparison with ¹⁸F-FMISO.
Chen L; Zhang Z; Kolb HC; Walsh JC; Zhang J; Guan Y
Nucl Med Commun; 2012 Oct; 33(10):1096-102. PubMed ID: 22836736
[TBL] [Abstract][Full Text] [Related]
20. [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors.
Sorger D; Patt M; Kumar P; Wiebe LI; Barthel H; Seese A; Dannenberg C; Tannapfel A; Kluge R; Sabri O
Nucl Med Biol; 2003 Apr; 30(3):317-26. PubMed ID: 12745023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
